MASA Valve Early Feasibility Study for Congenital Heart Defects

This study is testing a new device called the MASA Valve. It's designed to help children and young adults (up to 22 years old) who have certain heart conditions like Tetralogy of Fallot or Pulmonary Stenosis. The MASA Valve replaces a faulty pulmonary valve or a previously implanted device, helping blood flow correctly from the heart to the lungs. The main goal of this early study is to see if the MASA Valve is safe and works as intended, specifically looking at whether patients avoid device-related death, needing the device removed, or needing another surgery related to the device, all within one year. We are looking for about 10 participants for this study.

Study design
This is an interventional study, meaning participants will receive the MASA Valve. It aims to enroll about 10 participants.
What's involved
You would undergo surgery to replace your pulmonary valve with the MASA Valve. You would also need to return for follow-up appointments for one year after the surgery.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for one year after the surgery to assess the device's safety and effectiveness.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05452720

MASA Valve Early Feasibility Study

Recruiting
NAAges 0–22InterventionalDevice feasibility
PECA Labs
~10 participants
Updated 2024-11-06 on ClinicalTrials.gov
What's tested:Surgical Right Ventricular Outflow Tract Reconstruction

At a glance

Recruiting sites
5 of 5 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Freedom from device related death
Measured over 1 year
+6 more outcomes measured
Tetrology of Fallot
Pulmonary Stenosis
Truncus Arteriosus
Transposition of Great Vessels
Pulmonary Atresia
Ross Procedure

NCT05452720

Where you'd take part

This study runs at 5 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Boston Childrens Hospital

    Boston, Massachusettsstudy coordinator listed

    Recruiting

  • Childrens Hospital of Philadelphia

    Philadelphia, Pennsylvaniastudy coordinator listed

    Recruiting

  • Childrens Medical Center Dallas

    Dallas, Texasstudy coordinator listed

    Recruiting

  • Cincinnati Children's Hospital

    Cincinnati, Ohiostudy coordinator listed

    Recruiting

  • OSF Childrens Hospital of Illinois

    Peoria, Illinoisstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • David Morales, MD · PRINCIPAL_INVESTIGATOR · Cinncinnati Childrens Hospital

Opens a ready-to-send draft in your own email app — review before sending.

  • Freedom from device related death1 year

    Percentage of patients that have not died related to the device 1 year from implantation

  • Freedom from Explant1 year

    Percentage of patients that have not undergone device explant within 1 year from implantation

  • Freedom from Device-Related Reoperation1 year

    Percentage of patients that have not undergone re-operation related to the device within 1 year from implantation

  • Freedom from Device-Related Catheter Intervention1 year

    Percentage of patients that have not undergone device related catheter based intervention within 1 year from implantation

  • Freedom from Endocarditis1 year

    Percentage of patients that have not had endocarditis within 1 year from implantation

  • Freedom from Thrombus1 year

    Percentage of patients that have not had a serious thrombotic event related to the device within 1 year from implantation

  • Freedom from Major Hemorrhage1 year

    Percentage of patients that have not had a major bleeding episode related to the device within 1 year from implantation